PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

______ Nos. 14 - 4202, 14 - 4203, 14 - 4204, 14 - 4205, 14 - 4206, 14 - 4602 & 14 - 4632

______ IN RE: LIPITOR ANTITRUST LITIGATION Rite Aid Corporation ; Rite Aid Hdqtrs. Corporation; JC (PJC) USA, LL C; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd

Corporation,

Appellants in No. 14 - 4202 Walgreen Company; The Kroger Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company L.P., Appellants in No. 14 - 4203 Giant Eagle, Inc.,

Appellant in No. 14 - 4204 Meijer, Inc.; Meijer Distribution, Inc.,

Appellants in No. 14 - 4205 Rochester Drug Co - Operative, Inc.; Stephen L. LaFrance Pharmacy, Inc. d/b/a SA J Distributors; Burlington Drug Company, Inc.; Value Drug Company; Professional Drug Company, Inc .; American Sales Company LLC, Appellants in No. 14 - 42062 A.F.L. - A.G.C. Building Trades Welfare Plan; Mayor and City Council of Baltimore, M aryland; New Mexico United Food and Commercial Workers Union’s and Employers’ Health and Welfare Tru st Fund; Lou isiana Health Service Indemnity Company, d/b/a Blue Cross/B lue Shield of Louisiana; Bakers Local 433 Health Fund; Tw in Cities Bakery Workers Health and Welfare Fund; Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund; Int ernational Brotherhood of Electrical Workers Local 98; New York Hotel Trades Counsel & Hotel Association of New York City, Inc., Health Benefits Fund; Edward Czarnecki; Emilie Heinle; Frank Palter; Andrew Livezey; Edward Ellenson; Jea n Ellyne Dougan; Nancy Billington, on behalf of themselves and all

others similarly situated,

Appellants in No. 14 - 4602 RP Healthcar e, Inc.; Chimes Pharmacy, Inc.; James Clayworth, R.Ph., d/b/a Clayworth Pharmacy; Marin Apothecaries, Inc., d/b/a Ro ss Valley Pharmacy; Gold en Gate Pharmacy Services, In c., d/b/a Golden Gate Pharmacy; Pediatric Care Pharmacy, Inc.; Meyers Pharmacy, Inc.; Tony Mavrantonis R. Ph., d/b/a Jack’ s Drugs; Tilley Apothecaries

Inc., d/b/a Zweber’ s Apothecary,

Appellants in No. 14 - 46323 ______ Nos. 15 - 1184, 15 - 1185, 15 - 1186, 15 - 1187, 15 - 1274, 15 - 1323 & 15 - 1342

______ IN RE: EFFEXOR XR ANTITRUST LITIGATION Walgreen, Co.; The Kroger, Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company LP; American Sales Company, I nc., Appellants in No. 15 - 1184 Rite Aid Corporation; Rite Aid Hdqtrs., Corporation; JCG (PJC) USA, LLC; Maxi Dr ug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation; CVS Caremark Corporation, Appellants in No. 15 - 1185 Giant Eagle, Inc .,

Appellant in No. 15 - 1186 Meijer, Inc.; Meijer Distribution, Inc., Appellants in No. 15 - 1187 Professional Drug C ompany, Inc.; Rochester Drug Co Operative, Inc.; Stephen L. L aFrance Holdings, Inc.; Stephen L. LaFrance Phar macy, Inc. d/b/a SAJ Distributors;

Uniondale Chemist, Inc.,

Appellants in No. 15 - 12744 Painters District Council No. 30 Health & Welfare Fund;

Medical Mutual of Ohio,

Appellants in No. 15 - 1323 A.F.L. - A.G.C. Building Trades Welfare Plan; Daryl D eino; IBEW - NECA Local 505 Health & Welfare Plan; Louisiana Health Service Indemnit y Company d/b/a Blue Cross/Blue Shield of Louisiana; Man - U Service Contract Trust Fund; MC - UA Local 119 Health & Welfare Plan; New Mexico United Food and Commercial Workers U nion’ s and E mployers’ Health and Welfare Trust Fund; Plumbers and Pipefitters Loc al 572 Health and Welfare Fund; Sergeants Benevolent Assoc iation Health and Welfare Fund; Patricia Sutter (together “ End - Payor Class Plaintiffs”) on behalf of themselves and a ll others similarly situated, Appellants in No. 15 - 1342

______ On Appeal from the United States District Court for the District of New Jersey (MDL 2332) / (D.N.J. No. 3 - 12 - cv - 0 2389) / (D.N.J. No. 3 - 12 - cv - 0 2478) / (D.N.J. No. 3 - 12 - cv - 0 2519) / (D.N.J. No. 3 - 12 - cv - 0 4115) / (D.N.J. No. 3 - 12 - cv - 0 4537) / (D.N.J. No. 3 - 12 - cv - 0 5129) / (D.N.J. No. 3 - 12 - cv - 0 6774) / (D.N.J. No. 3 -

12 - cv - 0 7561) (D.N.J. No. 3 - 11 - cv - 0 5479) / (D.N.J. No. 3 - 11 - cv - 0 5590) / (D.N.J. No. 3 - 11 - cv - 0 5661) / (D.N. J. No. 3 - 11 - cv - 0 6985) / (D.N.J. No. 3 - 11 - cv - 0 7504) / (D.N.J. No. 3 - 12 - cv - 0 3116) /

(D.N.J. No. 3 - 12 - cv - 0 3523)

______ O RDER AMENDIN G O PINION5 ______ At the direction of the Court, the opinion filed on April 13, 2017 is amended as follows: Page 21, first full paragraph, third line: < four individual retailers asserting direct - purchaser claims > is changed to <several individual - retailers asserting direct - purchaser claims>. Page 21, first full paragraph, ninth line: delete <several> before <California - based pharmacists>. Page 25, only full paragraph, second line: <'983 Patent> is changed to <'893 Patent>. Page 28, fourth paragraph, fourth line: <four individual retailers asserting direct - purchaser claims> is changed to <several individual - retailers asserting direct - purchaser claims>. Page 31, second paragraph, fourth line: <four individual retailers filed complaints> is changed to <several individual retailers filed complaints>. Page 43, first full paragraph, first line: <Our jurisdictional holding is consistent, we think, with two of the Second Circuit’s pre - Actavis reverse - payment cases.> is changed to <Our jurisdictional holding is consistent, we think, with two of the Second Circuit’s pre - Actavis cases.>.6 Page 43, first full paragraph, tenth line: <(per curiam)> is added after <Arkansa s Carpenters Health & Welfare v. Bayer AG, 604 F.3d 98, 103 n.10 (2d Cir. 2010)>. Page 44, first full paragraph, first line: <And in DDAVP, 585 F.3d 677, the Second Circuit retained jurisdiction over a reverse - payment case.> is changed to <And in DDAVP, 5 85 F.3d 677, the Second Circuit retained jurisdiction over an antitrust case presenting patent - law issues.>. For the Court, Marcia M. Waldron, Clerk Date: April 19, 2017 mlr/cc: all counsel